Buergerinin G is primarily studied for its potential antimicrobial and antifungal properties. It has shown activity against certain drug-resistant strains of bacteria, making it a candidate for development in novel antibiotic therapies. Research also indicates possible antitumor effects, with observed inhibition of proliferation in select cancer cell lines. Due to its complex structure, it serves as a lead compound in medicinal chemistry for designing derivatives with enhanced bioactivity and selectivity. Its natural origin and biological profile support ongoing exploration in pharmaceutical applications, particularly in targeting resistant infections and oncology-related research.